Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Enduracaine
- Development stage
- Phase 4
- Lead developer
- Balanced Pharma
- Modality
- Small Molecules
- Administration
- Injectable
01
Overview
Enduracaine (BPI-004) is a non-opioid, long-acting local analgesic combination being developed by Balanced Pharma for the management of post-surgical pain. The drug is a patented formulation of tetracaine (0.2%), lidocaine (0.4%), and epinephrine (1:250,000), designed to provide up to 72 hours of analgesia following a single local injection. Originally marketed as a compounding kit called Endura-KT by Ventis Pharma, Balanced Pharma is reformulating the product into stable, pre-filled syringes and dental cartridges with a two-year shelf life. Enduracaine is intended for use across a wide range of surgical specialties, including orthopedic, oral, maxillofacial, general, podiatric, gynecological, and cardiothoracic surgery, aiming to reduce the reliance on post-operative opioids.
- Brand names
- Enduracaine
- Other names
- Endura-KT
02
Targets
ADRA2A (α2A)ADRB1 (β1)β-AR (Beta-adrenergic receptor family)ADRA1A (α1A)NaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on Enduracaine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Enduracaine.